Next Article in Journal
Microbiome Associations of Therapeutic Enteral Nutrition
Next Article in Special Issue
The Role of Dietary Fat throughout the Prostate Cancer Trajectory
Previous Article in Journal
Anti-Inflammatory Activity of Fruit Fractions in Vitro, Mediated through Toll-Like Receptor 4 and 2 in the Context of Inflammatory Bowel Disease
Previous Article in Special Issue
The Role of n-3 Polyunsaturated Fatty Acids in the Prevention and Treatment of Breast Cancer
Article Menu

Export Article

Open AccessReview
Nutrients 2014, 6(11), 5280-5297;

Evidence and Mechanisms of Fat Depletion in Cancer

Division of Human Nutrition, Department of Agricultural, Food and Nutritional Science, University of Alberta, 4-002 Li Ka Shing Centre for Health Research Innovation, Edmonton, AB T6G 2E1, Canada
Author to whom correspondence should be addressed.
Received: 5 August 2014 / Revised: 19 September 2014 / Accepted: 10 October 2014 / Published: 19 November 2014
(This article belongs to the Special Issue Nutrition and Cancer)
Full-Text   |   PDF [202 KB, uploaded 19 November 2014]   |  


The majority of cancer patients experience wasting characterized by muscle loss with or without fat loss. In human and animal models of cancer, body composition assessment and morphological analysis reveals adipose atrophy and presence of smaller adipocytes. Fat loss is associated with reduced quality of life in cancer patients and shorter survival independent of body mass index. Fat loss occurs in both visceral and subcutaneous depots; however, the pattern of loss has been incompletely characterized. Increased lipolysis and fat oxidation, decreased lipogenesis, impaired lipid depositionand adipogenesis, as well as browning of white adipose tissue may underlie adipose atrophy in cancer. Inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1 beta (IL-1β) produced by the tumor or adipose tissue may also contribute to adipose depletion. Identifying the mechanisms and time course of fat mass changes in cancer may help identify individuals at risk of adipose depletion and define interventions to circumvent wasting. This review outlines current knowledge of fat mass in cancer and illustrates the need for further studies to assess alterations in visceral and subcutaneous adipose depots and possible mechanisms for loss of fat during cancer progression. View Full-Text
Keywords: adipose tissue; cancer; computed tomography; fat mobilization adipose tissue; cancer; computed tomography; fat mobilization

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ebadi, M.; Mazurak, V.C. Evidence and Mechanisms of Fat Depletion in Cancer. Nutrients 2014, 6, 5280-5297.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top